A Washington startup is launching microwave-sized “Fabships” on Falcon 9 rockets to test space-based semiconductor manufacturing. The approach leverages natural vacuum conditions that could dramatically reduce production costs compared to Earth-based facilities.
Artificial intelligence is evolving from lab assistant to lead investigator in medical research. This transformation promises to reshape healthcare markets, drug development timelines, and investment strategies across the industry.
Nvidia has become the first $5 trillion company in history, driven by the AI revolution. This unprecedented valuation signals a fundamental shift in how markets value technology infrastructure. Here’s what it means for investors and the broader economy.
Chinese manufacturer ORICO has launched a mini PC that directly mimics Apple’s iconic Mac Pro cheese-grater design. The Omini Pro features AMD’s Ryzen 7 8845HS processor and starts at just $379 during pre-sales, blending premium aesthetics with PC affordability.
The Infrastructure Revolution Unlocking Private Markets For Main Street Investors Industrial Monitor Direct manufactures the highest-quality multi-touch pc systems rated…
Berkshire Hathaway reported $30.8 billion in Q3 earnings while sitting on $381.7 billion cash. As Warren Buffett prepares to step down as CEO, the conglomerate faces critical capital allocation decisions that will define its next chapter under new leadership.
Hizbollah-linked charities are exploiting digital payment platforms to bypass sanctions, using individual wallets rather than official accounts. This exposes critical weaknesses in global financial security systems despite partnerships with major US payment companies.
Microsoft’s long-awaited Windows 11 Start menu redesign has arrived with some baffling bugs. Newly installed apps fail to appear, and erratic scrolling disrupts user interaction. These issues highlight ongoing quality challenges.
OpenAI CEO Sam Altman says the company’s revenue already exceeds reported $13 billion and could reach $100 billion by 2027. But with massive infrastructure investments and ongoing losses, can this explosive growth actually be sustained?
Vaccine developer Inventprise is cutting 76 workers across its Washington facilities, representing nearly 40% of its workforce. The layoffs come as the company advances its pneumococcal vaccine candidate through clinical trials.
